within Pharmacolibrary.Drugs.ATC.M;

model M01AE03
  extends Pharmacokinetic.Models.PK_2C_enteral(
    weight         = 70,
    F              = 0.9,
    Cl             = 1.1666666666666668e-06,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.025,
    Tlag           = 10.200000000000001,            
    Vdp             = 0.00011999999999999999,
    k12             = 0.12,
    k21             = 0.12
    
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>M01AE03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of pain, inflammation, and fever. It is commonly prescribed for musculoskeletal disorders, arthritis, and mild to moderate pain. It is approved and currently in use in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters observed in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Porażka, J, Karbownik, A, Murawa, D, Spychała, A, Firlej, M, Grabowski, T, Murawa, P, Grześkowiak, E, &amp; Szałek, E (2017). The pharmacokinetics of oral ketoprofen in patients after gastric resection. <i>Pharmacological reports : PR</i> 69(2) 296–299. DOI:<a href=&quot;https://doi.org/10.1016/j.pharep.2016.11.010&quot;>10.1016/j.pharep.2016.11.010</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28178590/&quot;>https://pubmed.ncbi.nlm.nih.gov/28178590</a></p></li><li><p>Lorier, M, Magallanes, L, Ibarra, M, Guevara, N, Vázquez, M, &amp; Fagiolino, P (2016). Stereoselective Pharmacokinetics of Ketoprofen After Oral Administration of Modified-Release Formulations in Caucasian Healthy Subjects. <i>European journal of drug metabolism and pharmacokinetics</i> 41(6) 787–793. DOI:<a href=&quot;https://doi.org/10.1007/s13318-015-0313-2&quot;>10.1007/s13318-015-0313-2</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26590950/&quot;>https://pubmed.ncbi.nlm.nih.gov/26590950</a></p></li><li><p>Derry, S, Conaghan, P, Da Silva, JA, Wiffen, PJ, &amp; Moore, RA (2016). Topical NSAIDs for chronic musculoskeletal pain in adults. <i>The Cochrane database of systematic reviews</i> 4(4) CD007400–None. DOI:<a href=&quot;https://doi.org/10.1002/14651858.CD007400.pub3&quot;>10.1002/14651858.CD007400.pub3</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/27103611/&quot;>https://pubmed.ncbi.nlm.nih.gov/27103611</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end M01AE03;
